Korean Circ J.  2020 Oct;50(10):955-956. 10.4070/kcj.2020.0109.

Primary Pericardial Angiosarcoma: an Insidious and Aggressive Malignant Tumor

Affiliations
  • 1Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
  • 2Heart Rhythm Center and Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
  • 3Department of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan


Figure

  • Figure 1 Primary pericardial angiosarcoma. (A) CMR image revealed a huge hyperintense T1-weighted mass at pericardial space with right atrial compression. (B) TEE demonstrated the tumor, located adjacent to RA and SVC. (C) The excised tumor, in size of 5.5×4.5 cm, showed prominent necrosis and hemorrhage. (D) Pericardial soft tissue with infiltration of malignant endothelial cells (H&E, ×40). (E) The tumor cells were positive for CD34 immunohistochemical staining (×200).CMR = cardiac magnetic resonance; H&E = hematoxylin and eosin stain; IVC = inferior vena cava; RA = right atrium; SVC = superior vena cava; TEE = transoesophageal echocardiography; TM = tumor mass.


Reference

1. Timóteo AT, Branco LM, Bravio I, et al. Primary angiosarcoma of the pericardium: case report and review of the literature. Kardiol Pol. 2010; 68:802–805. PMID: 20648441.
2. Meng Q, Lai H, Lima J, Tong W, Qian Y, Lai S. Echocardiographic and pathologic characteristics of primary cardiac tumors: a study of 149 cases. Int J Cardiol. 2002; 84:69–75. PMID: 12104067.
Article
3. Holtan SG, Allen RD, Henkel DM, et al. Angiosarcoma of the pericardium presenting as hemorrhagic pleuropericarditis, cardiac tamponade, and thromboembolic phenomena. Int J Cardiol. 2007; 115:e8–9. PMID: 16904210.
Article
4. Shi X, Li F. Primary pericardial angiosarcoma shown on FDG PET/CT. Clin Nucl Med. 2017; 42:973–975. PMID: 29076895.
Article
Full Text Links
  • KCJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr